Collaborations & Alliances
Related Searches:
Filter by:
46 - 60 of 1104 results
April 9, 2013
Acquires rights to Tykerb in China
Read More »
April 8, 2013
Regains all commercialization rights
Read More »
April 5, 2013
Will evaluate VX-135 and daclatasvir in hepatitis C
Read More »
April 5, 2013
Will use conjugation technology to develop ADCs in oncology
Read More »
April 4, 2013
To develop CHO cell lines and assess product attributes for proteins
Read More »
April 4, 2013
To develop novel antibody program from X-BODY platform
Read More »
April 3, 2013
Will develop and commercialize multiple Accurins
Read More »
April 3, 2013
Gains access to Captisol technology
Read More »
April 2, 2013
SK to develop and commercialize THVD-201 and THVD-202
Read More »
April 2, 2013
Extreme Diversity platform will help develop candidates
Read More »
April 2, 2013
Will use Tetragenetics technology platform for antibody production
Read More »
March 28, 2013
Aims to identify new approaches to metabolic disease
Read More »
March 28, 2013
Receives $35 mil. upfront for orphan treatments
Read More »
March 27, 2013
Aims to identify inhibitors that play a role in tissue protection and repair
Read More »
March 26, 2013
To co-develop and commercialize Lu AE58054
Read More »
46 - 60 of 1104 results
